RecruitingNot applicableNCT05813678
A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)
Studying Phenylketonuria
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- BioMarin Pharmaceutical
- Principal Investigator
- Medical Director, MD, M.DBioMarin Pharmaceutical
- Intervention
- Pegvaliase(drug)
- Enrollment
- 450 enrolled
- Eligibility
- All sexes
- Timeline
- 2022 – 2033
Study locations (16)
- University of Colorado, Aurora, Colorado, United States
- Northwestern University, Chicago, Illinois, United States
- Indiana University School of Medicine, Indianapolis, Indiana, United States
- Tulane University Medical Center, New Orleans, Louisiana, United States
- Oregon Health and Science University, Portland, Oregon, United States
- University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
- University of Texas Southwestern Medical Center, Dallas, Texas, United States
- Medical College of Wisconsin, Milwaukee, Wisconsin, United States
- Hospital Carl-Thiem-Klinikum Cottbus, Cottbus, Germany
- Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany
- Universitätsklinikum Münster (UKM)-Pädiatrische Universitätsklinik Münster, Münster, Germany
- Universität Ulm, Ulm, Germany
- Policlinico Sant'orsola Malpighi, Bologna, Italy
- University Hospital Careggi, Florence, Italy
- Ospedale San Paolo, Milan, Italy
- +1 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05813678 on ClinicalTrials.govOther trials for Phenylketonuria
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT06971731A Study to Evaluate the Safety and Efficacy of JNT-517 in Participants With Phenylketonuria (PKU)Otsuka Pharmaceutical Development & Commercialization, Inc.
- ACTIVE NOT RECRUITINGPHASE1NCT07255599Evaluation of BH4 Responsiveness in Our PKU PatientsSohag University
- RECRUITINGNANCT06941532GMP Powdered Substitutes in PKU and TYRNutricia UK Ltd
- ENROLLING BY INVITATIONNANCT06940193A Self-test Home-use Blood Phenylalanine Monitoring System Under the Brand Name Egoo Phe System Has Been Developed for Measurement of Phenylalanine (Phe) in Individuals Diagnosed With Phenylketonuria (PKU): The Study Purpose is to Evaluate Accuracy and UsabilityEgoo Health Aps
- ACTIVE NOT RECRUITINGPHASE4NCT06901323Effect of L-carnitine Supplementation on Phenylalanine and Brain-derived Neurotrophic Factor Levels in Infants and Children With PhenylketonuriaMansoura University
- RECRUITINGNANCT06969209Brain Aging in PhenylketonuriaInsel Gruppe AG, University Hospital Bern
- RECRUITINGPHASE1NCT06332807AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom)NGGT INC.
- RECRUITINGNANCT06560736Development of Novel Psychological Assessment Tools and Anxiety Intervention for PhenylketonuriaUniversity of Missouri-Columbia